where was glp 1 discovered GLP-1 receptor assay: drug discovery in the metabolic field Evolution of GLP‐1 Receptor Agonists

Theres a reason why everyone is talking about weight loss injections

What are the recommendations for a patient with a Body Mass Index (BMI) less than 22 who is taking Glucagon-Like Peptide-1 (GLP-1) receptor agonists, such as semaglutide (GLP-1 receptor agonist) or tirzepatide (GLP-1 and glucose-dependent insulinotropic polypeptide receptor agonist), for weight loss?

Lastly, keep in mind why youre experiencing these side effects: they are directly related to how the medication works (slowing gastric emptying, altering hormones)

Importantly, treatment response appears to vary by metabolic status, with greater efficacy reported in individuals with obesity, suggesting the need for precision approaches